These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27136634)

  • 1. Lichen planus-like drug reaction associated with recombinant human growth hormone therapy in a child patient with Turner syndrome.
    Soares MQ; Mendonca EF
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lichenoid drug eruption in a child with Turner syndrome: A rare adverse reaction of recombinant human growth hormone.
    Lin N; Lai K; Wang M
    Australas J Dermatol; 2018 Nov; 59(4):e311-e313. PubMed ID: 29900541
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term safety of recombinant human growth hormone in turner syndrome.
    Bolar K; Hoffman AR; Maneatis T; Lippe B
    J Clin Endocrinol Metab; 2008 Feb; 93(2):344-51. PubMed ID: 18000090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lichen planus associated with etanercept.
    Battistella M; Rivet J; Bachelez H; Lioté F
    Br J Dermatol; 2008 Jan; 158(1):188-90. PubMed ID: 17944978
    [No Abstract]   [Full Text] [Related]  

  • 5. Ulcerative lichen planus-like dermatitis associated with hydroxyurea.
    Renfro L; Kamino H; Raphael B; Moy J; Sanchez M
    J Am Acad Dermatol; 1991 Jan; 24(1):143-5. PubMed ID: 1825667
    [No Abstract]   [Full Text] [Related]  

  • 6. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lichenoid photoreactive epidermal necrosis with diflunisal.
    Street ML; Winkelmann RK
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):850-1. PubMed ID: 2715433
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic effects of growth hormone combined with low-dose stanozolol on growth velocity and final height of girls with Turner syndrome.
    Xiong H; Chen HS; Du ML; Li YH; Ma HM; Su Z; Chen QL
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):223-8. PubMed ID: 25824243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis.
    Suwattee P; Chow S; Berg BC; Warshaw EM
    Arch Dermatol; 2008 Jan; 144(1):123-5. PubMed ID: 18209189
    [No Abstract]   [Full Text] [Related]  

  • 10. Violaceous plaques in a patient with acquired immunodeficiency syndrome.
    Bessinger GT; Conologue TD; Krivda SJ; Turiansky GW
    Arch Dermatol; 2003 Feb; 139(2):215-20. PubMed ID: 12588229
    [No Abstract]   [Full Text] [Related]  

  • 11. The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.
    Braz AF; Costalonga EF; Montenegro LR; Trarbach EB; Antonini SR; Malaquias AC; Ramos ES; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E671-7. PubMed ID: 22278433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone in turner syndrome.
    Khadilkar VV; Khadilkar AV; Nandy M; Maskati GB
    Indian Pediatr; 2006 Mar; 43(3):236-40. PubMed ID: 16585818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of palmoplantar lichen planus with various clinical features.
    Kim MJ; Choi M; Na SY; Lee JH; Cho S
    J Dermatol; 2010 Nov; 37(11):985-9. PubMed ID: 21039788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Turner Syndrome and Growth Hormone Deficiency: A Review.
    Marques JS; Aires S
    Pediatr Endocrinol Rev; 2015 Sep; 13(1):455-7. PubMed ID: 26540761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of thyroid autoimmunity and the response to recombinant human growth hormone in Turner syndrome.
    Song Y; Yang H; Wang L; Gong F; Pan H; Zhu H
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):465-471. PubMed ID: 33662192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Palmoplantar cutaneous reaction to sorafenib].
    Echeverría B; Llombart B; Botella-Estrada R; Guillén C
    Actas Dermosifiliogr; 2009 Oct; 100(8):736-7. PubMed ID: 19775561
    [No Abstract]   [Full Text] [Related]  

  • 17. Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur.
    Jucglà A; Sais G; Navarro M; Peyri J
    Arch Dermatol; 1995 Mar; 131(3):364-5. PubMed ID: 7887678
    [No Abstract]   [Full Text] [Related]  

  • 18. Why Treat girls with Turner Syndrome with Growth Hormone? Growth and Beyond.
    Ranke MB
    Pediatr Endocrinol Rev; 2015 Jun; 12(4):356-65. PubMed ID: 26182480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concurrent presence of an oral lichenoid drug reaction and an oral lichen planus.
    Baer PN; Goldenhar M
    Periodontal Case Rep; 1983; 5(2):33-5. PubMed ID: 6228948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.